[Effect of the German Act on the reform of the market for medicinal products (AMNOG) on the quality of neurological and psychiatric treatment]. [electronic resource]
Producer: 20170106Description: 351-2 p. digitalISSN:- 1433-0407
- Drug Approval -- economics
- Drug Industry -- legislation & jurisprudence
- Germany
- Government Regulation
- Health Care Reform -- economics
- Legislation, Drug
- Marketing of Health Services -- economics
- Neurology -- economics
- Outcome Assessment, Health Care -- economics
- Psychotherapy -- economics
- Quality Assurance, Health Care -- economics
No physical items for this record
Publication Type: Editorial
There are no comments on this title.
Log in to your account to post a comment.